Posted by tecknohed on October 16, 2005, at 7:44:19
Anyone know anything about New River Pharmaceuticals' new NRP104 drug (D-amphetamine bonded with Lysine), targeted for the treatment of ADHD? Its said to have less abuse potential than other stims - "Because it is inactive until metabolized in the GI tract, it may offer the advantage of reduced potential for abuse or overdose and may have a unique safety profile versus traditional stimulants"
http://www.medicalnewstoday.com/medicalnews.php?newsid=18555
How exactly would this reduce abuse and overdose potential? Sounds to good to be true! It was in phase 3 in Jan this year. Anyone know its current situation?
poster:tecknohed
thread:567520
URL: http://www.dr-bob.org/babble/20051010/msgs/567520.html